Danica Michaličková

8PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthPharmacogenomicsEpidemiological modellingRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 19, 2025
Safety and efficacy of antigen-specific therapeutic approaches for multiple sclerosis: Systematic review.

Hatice Kübra Öztürk, Ondřej Slanař, Danica Michaličková

|May 24, 2024
Meropenem Disposition in Neonatal and Pediatric Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.

Pavla Pokorná, Danica Michaličková, Dick Tibboel

|May 27, 2023
Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications.

Jan Miroslav Hartinger, Danica Michaličková, Eliška Dvořáčková

|Nov 11, 2022
Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation.

Petr Šantavý, Martin Šíma, Ondřej Zuščich

|Sep 16, 2021
Correction to: Population pharmacokinetics‑pharmacodynamics of fondaparinux in dialysis‑dependent chronic kidney disease patients undergoing chronic renal replacement therapy.

Danica Michaličková, Jan Miroslav Hartinger, Zuzana Hladinová

|Aug 28, 2021
No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses.

Martin Šíma, Danica Michaličková, Pavel Ryšánek

Pageof 2

Frequent Collaborators

2 joint publications

Martin Šíma

1 joint publications

Pavel Ryšánek

1 joint publications

Petra Cihlářová

1 joint publications

Karel Urbánek